Revisiting Prophylaxis of Homeopathic Interventions in COVID 19
Homoeoprophylaxis |Immunoglobulin |Sars-cov-2
; 2021(International Journal of High Dilution Research)
Article
in English
| WHO COVID | ID: covidwho-1675717
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused by novel beta-coronavirus has emerged as a cause of coronavirus pandemic (COVID-19) declared by Public Health Emergency of International Concern (PHEIC). Korean oriental medicine, Traditional Chinese Medicine (TCM), and Indian systems of medicine known as AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Sowa-Rigpa and Homeopathy) had implemented various prophylactic measures and interim treatment guidelines in prevention and treatment for COVID -19 cases. However, even though different approaches were implemented to break the epidemic chain, we have not reached herd effect or herd immunity in the Indian population. Therefore, in this ongoing COVID-19 pandemic, a specific study on immune markers of IL-6 (Interleukin-6), D-Dimer, Ferritine, CRP (C-reactive protein) with SARS CoV-2 specific IgG & IgM antibodies need to be investigated for generating hard-core evidence for homeoprophylaxis in terms of immunity response. Therefore, there seems to be a need to revisit the program of homeoprophylaxis in the COVID -19 pandemic © International Journal of High Dilution Research
Full text:
Available
Collection:
Databases of international organizations
Database:
WHO COVID
Type of study:
Experimental Studies
Topics:
Traditional medicine
Language:
English
Journal:
Homoeoprophylaxis |Immunoglobulin |Sars-cov-2
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS